Keros Therapeutics
KROS
#6165
Rank
HK$5.36 B
Marketcap
HK$132.32
Share price
0.65%
Change (1 day)
-53.37%
Change (1 year)

Keros Therapeutics (KROS) Fails to deliver data

Key failure to deliver metrics for Keros Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Keros Therapeutics (KROS) - 3 months history

Number of shares, 3 months chart

Sep 2024Oct 20245K10K15K20K25K30K0companiesmarketcap.com

Biweekly Failures to deliver volume for Keros Therapeutics (KROS) - since 2020

Volume in USD (price x number of shares), data since 2020 2021202220232024$5M$10M$15M0companiesmarketcap.com

Keros Therapeutics (KROS) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024HK$6.5 M-2.1%
2023HK$6.64 M3.04%
2022HK$6.45 M-72.87%
2021HK$23.77 M128.32%
2020HK$10.41 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
HK$1 MHK$6 M๐Ÿ‡บ๐Ÿ‡ธ USA